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Objective: While substituted phenols have a variety of pharmacological activity, the mechanism 
underlying their anesthetic effects remains uncertain especially about the critical target. We cha-
racterized the lipid membrane-interacting properties of different phenols by comparing with 
general anesthetic propofol and local anesthetics. Based on the results, we also studied the phar-
macological effects possibly associated with their membrane interactivities. Methods: 1,6-Di- 
phenyl-1,3,5-hexatriene-labeled lipid bilayer membranes were prepared with 1,2-dipalmitoyl- 
phosphatidylcholine as model membranes and with different phospholipids and cholesterol to 
mimic neuronal membranes. These membrane preparations were treated with phenols and anes-
thetics at 1 - 200 μM, followed by measuring the fluorescence polarization to determine the mem-
brane interactivities to change membrane fluidity. Antioxidant effects were fluorometrically de-
termined using diphenyl-1-pyrenylphosphine-incorporated liposomes which were treated with 
10 - 100 μM phenols, and then peroxidized with 10 μM peroxynitrite. Results: Several phenols in-
teracted with the model membranes and the neuronal mimetic membranes to increase their fluid-
ity at 1 - 10 μM as well as lidocaine and bupivacaine did at 50 - 200 μM. Their comparative poten-
cies were propofol > thymol > isothymol > guaiacol > phenol > eugenol, and bupivacaine > lido-
caine, consistent with the rank order of neuro-activity. These phenols inhibited membrane lipid 
peroxidation at 10 and 100 μM with the potencies correlating to their membrane interactivities. 
Conclusion: The structure-specific membrane interaction is at least in part responsible for the 
pharmacology of anesthetic alkylphenols. Membrane-interacting antioxidant alkylphenols may be 
protective against the peroxynitrite-relating ischemia/reperfusion injury. 
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Since phenol was introduced as a surgical disinfectant in the 1860s, substituted phenols or phenol derivatives 
have been applied as antiseptic, antibacterial, analgesic and anti-inflammatory agents. In addition, many of them 
possess the local anesthetic activity, making them very useful in dentistry when the relevant pain is associated 
with infection and inflammation. Phenolic agents are extensively used to allay the pain of dental pulps or sedate 
the inflamed pulps and to disinfect root canals and dentins. Orally and intravenously administered phenols are 
also effective for inflammatory and peripheral/central nervous pains [1] [2]. In the anesthesiology field, propofol 
is certainly best known of medicinal phenols. Intravenous anesthetic propofol has been widely used to induce 
and maintain general anesthesia, as a part of total intravenous anesthesia and for procedural sedation. The other 
alkylphenols also show the neuro-activity through the affinity for GABAA receptors similarly to propofol [3] [4]. 
As suggested by Haeseler and Leuwer [5], a benzene ring with some substituents is the structural characteris-
tics for pharmacologically active agents such as pulp-sedative thymol, eugenol and guaiacol, general anesthetic 
propofol and local anesthetic lidocaine (see Figure 1 for their structures). In addition to analgesic and anesthetic 
effects, alkylphenols have antimicrobial, anti-inflammatory, antithrombotic and anticancer effects [6]-[8]. How- 
ever, the molecular mechanisms to explain such diversity in pharmacological activity have not necessarily been 
elucidated especially about the critical target. 
Drugs and chemicals mechanistically act not only on receptor, channel and enzyme proteins but also on 
membrane lipids and their constituting lipid bilayers, thereby inhibiting or reducing bacterial growth, inflamma-
tory reaction, platelet aggregation and tumor cell proliferation. Antimicrobial [9], non-steroidal anti-inflamma- 
tory [10], antiplatelet [11] and antiproliferative drugs [12] change the physicochemical properties such as fluidi-
ty, order and elasticity of biological and artificial lipid membranes by interacting with membrane lipids. Since 
antimicrobial, anti-inflammatory, antiplatelet and anticancer phenols and their structurally-relating compounds 
act on biomembranes [13] [14], the interactivity with lipid bilayers is presumed to be one of principal characte-
ristics in common with phenolic agents. 
Both local anesthetics and general anesthetic propofol block voltage-operated ion channels, but they differ-
ently act on GABAA receptors. Lidocaine, bupivacaine and procaine inhibit GABA-induced currents, possibly 
 
 
Figure 1. Phenols and anesthetics tested in this study.                                              
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producing their CNS toxicity [15], whereas propofol potentiates GABA-evoked currents and directly activates 
GABAA receptors [5]. Thymol, eugenol and guaiacol share the effects on peripheral and central nerves with li-
docaine and propofol, respectively. These dental phenols block voltage-operated ion channels and inhibit so-
dium currents as well as local anesthetics [16] [17], although they allosterically positively modulate GABAA re-
ceptors similarly to propofol [3] [4]. 
The physicochemical properties of lipid bilayer membranes regulate voltage-dependent sodium channel and 
GABAA receptor functions [18] [19]. Besides membrane-embedded channels and receptors, local and general 
anesthetics possibly interact with membrane lipids to modify the lipid environments surrounding functional pro-
teins as the primary mode of action. In this study, we characterized the lipid membrane-interacting properties of 
structurally-different anesthetic phenols (Figure 1) by comparing with general and local anesthetics. We also 
studied the pharmacological effects which could be associated with their membrane interactivities. 
2. Methods 
2.1. Chemicals 
Phenolic thymol (5-methyl-2-isopropylphenol), isothymol (4-methyl-2-isopropylphenol), 3-methyl-4-isopropyl- 
phenol (MIP), eugenol (2-methoxy-4-(2-propenyl)phenol), isoeugenol (2-methoxy-4-(1-propenyl)phenol), 
guaiacol (2-methoxyphenol), phenol and propofol (2,6-diisopropylphenol), local anesthetic lidocaine and bupi-
vacaine, and antioxidant α-tocopherol were supplied by Aldrich (Milwaukee, WI), Sigma (St. Louis, MO), Wa-
ko Pure Chemicals (Osaka, Japan) or Tokyo Chemical Industrials (Tokyo, Japan). Phospholipids: 1,2-dipalmi- 
toylphosphatidylcholine (DPPC),1-palmitoyl-2-oleoylphosphatidylcholine (POPC), 1-palmitoyl-2-oleoylphos- 
phatidylethanolamine (POPE), 1-palmitoyl-2-oleoylphosphatidylserine (POPS) and porcine brain sphingomyelin 
(SM) were purchased from Avanti Polar Lipids (Alabaster, AL), and cholesterol from Wako Pure Chemicals. 
1,6-Diphenyl-1,3,5-hexatriene (DPH) was obtained from Molecular Probes (Eugene, OR), and diphenyl-1-py- 
renylphosphine (DPPP) and peroxynitrite from Dojindo (Kumamoto, Japan). Dimethyl sulfoxide (DMSO) and 
ethanol of spectroscopic grade (Kishida; Osaka, Japan) and water of liquid chromatographic grade (Kishida) 
were used for preparing reagent solutions. All other chemicals were of the highest analytical grade available 
commercially. 
2.2. Membrane Preparation 
Lipid bilayer membranes were prepared as reported previously [20] with some modifications as follows. An 
aliquot (250 µl) of the ethanol solution of phospholipids and cholesterol (total lipids of 10 mM) and DPH (50 
µM) was repeatedly injected four times into 199 ml of 20 mM sodium phosphate buffer (pH 7.4, containing 100 
mM KCl) under stirring above the phase transition temperatures of phospholipids to prepare DPH-labeled un-
ilamellar vesicles suspended in the buffer. Their lipid compositions were (1) 100 mol% DPPC for DPPC model 
membranes which have been most frequently used for studying membrane-active drugs and (2) 36 mol% POPC, 
22 mol% POPE, 3.5 mol% POPS, 3.5 mol% SM and 35 mol% cholesterol to mimic neuronal membranes. 
2.3. Interaction with Lipid Membranes 
The DMSO solutions of thymol, isothymol, MIP, eugenol, isoeugenol, guaiacol, phenol, propofol, lidocaine and 
bupivacaine were applied to the membrane preparations so that final concentrations were 1 - 200 μM. The con-
centration of DMSO vehicle was adjusted to be 0.5% (v/v) of the total volume so as not to affect the fluidity of 
intact membranes. DMSO of the corresponding volume was added to controls. After the reaction at 37˚C for 15 
min, DPH fluorescence polarization was measured by an RF-540 spectrofluorometer (Shimadzu; Kyoto, Japan) 
equipped with a polarizer and a cuvette thermo-controller as reported previously [20]. Polarization values were 
calculated by the formula (IVV – GIVH)/(IVV + GIVH), in which I is the fluorescence intensity and the subscripts V 
and H refer to the vertical and horizontal orientation of the excitation and emission polarizer, respectively. The 
grating correction factor (G = IHV/IHH) was used to correct the polarizing effects of a monochromator. Compared 
with controls, a decrease of fluorescence polarization means an increase of membrane fluidity (membrane flui-
dization). Because the DPH polarization values of control membranes vary depending on membrane lipid com-
ponents and their compositions, the polarization changes (%) relative to control polarization values were used 
for comparing the fluidity-modifying potencies between different membranes. 
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2.4. Inhibition of Membrane Lipid Peroxidation 
The antioxidant activity was determined by the liposomal system reported previously with some modifications 
[21]. An aliquot (250 µl) of the ethanol solution of 10 mM total lipids and 40 µM DPPP was repeatedly injected 
four times into 199 ml of Dulbecco’s phosphate-buffered saline of pH 7.4 (Dainippon Pharmaceuticals; Osaka, 
Japan) to prepare DPPP-incorporated liposomes suspended in the buffer. The lipid composition of liposomal 
membranes was the same as that of neuronal mimetic membranes described in Section 2.2. To the liposome 
suspensions of 3.97 ml, 10 µl of phenols and reference antioxidant α-tocopherol solutions in DMSO were added 
to be final concentrations of 10 and 100 µM for phenols and 1 µM for α-tocopherol, followed by incubation at 
37˚C for 30 min. A corresponding volume (0.25%, v/v) of DMSO vehicle was added for controls. The resulting 
suspensions were incubated with 20 μl of a peroxynitrite solution in 0.1 M NaOH to peroxidize membrane lipids 
with 10 µM peroxynitrite. A membrane-incorporated DPPP quantitatively reacts with a lipid hydroperoxide to 
produce a fluorescent phosphine oxide in lipid bilayers. After the incubation at 37˚C for 10 min, the liposome 
suspensions were fluorometrically analyzed at 355 nm for excitation and at 382 nm for emission. When the pe-
roxynitrite-induced increase of fluorescence intensity reached a plateau, the lipid peroxidation was defined as 
completed (100%). The lipid peroxidation inhibitions (%) were determined by comparing the fluorescence in-
tensity with controls. The fluorescence intensity of liposome suspensions treated with DMSO alone was sub-
tracted from that of liposome suspensions treated with phenols plus DMSO so that the determined effects were 
not affected by vehicles. 
2.5. Statistical Analysis 
All results are expressed as means ± SEM (n = 6 for membrane interaction experiments and n = 5 for lipid pe-
roxidation experiments). Data were statistically analyzed by a one-way analysis of variance (ANOVA), followed 
by a post hoc Fisher’s protected least significant difference (PLSD) test using StatView 5.0 (SAS Software; 
Cary, NC). P values of 0.05 or less were regarded as statistically significant. 
3. Results 
3.1. Effects on DPPC Membranes 
In pilot studies using DPPC model membranes, the membrane-interacting potentials of phenols and anesthetics 
were confirmed (Figure 2). Except for MIP and isoeugenol, phenols increased the DPPC membrane fluidity at  
 
 
Figure 2. Effects of phenols and local anesthetics on DPPC model membranes. 
DPPC membranes were treated with phenols (10 μM for each) and local anes-
thetics (200 μM for each), followed by measuring DPH fluorescence polariza-
tion. The polarization changes (%) relative to control values are shown as 
means ± SEM (n = 6). *P < 0.05 and **P < 0.01 compared with control.        
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10 μM as well as lidocaine and bupivacaine did at 200 μM. Their comparative potencies were propofol > thy-
mol > isothymol > guaiacol > phenol > eugenol, and bupivacaine > lidocaine. At concentrations higher than 200 
μM, alkylphenols such as propofol and thymol induced the aggregation of DPPC unilamellar vesicles as pre-
viously reported for polyphenols that aggregated phosphatidylcholine liposomes [22]. 
3.2. Effects on Neuronal Mimetic Membranes 
Phenols other than isoeugenol interacted with neuronal mimetic membranes to increase their fluidity at 10 μM 
(Figure 3). Propofol was most potent of phenols as shown by the significant DPH polarization decrease at 1 μM, 
followed by thymol, isothymol, guaiacol, phenol, eugenol and MIP. Local anesthetics also increased the fluidity 
of neuronal mimetic membranes at 50 - 200 μM with the comparative potency being bupivacaine > lidocaine. 
The membrane effects of both local anesthetics were weaker than those of membrane-interacting phenols. Com- 
pared with DPPC model membranes, the membrane fluidity decreases by phenols and local anesthetics were 
smaller. 
3.3. Effects on Membrane Lipid Peroxidation 
While being not as potent as antioxidant α-tocopherol, all the tested phenols inhibited peroxynitrite-induced 
membrane lipid peroxidation at 10 and 100 μM (Figure 4). When the lipid peroxidation inhibitions (%) at 10 
μM for each were plotted against the induced polarization changes (%) of neuronal mimetic membranes, the li-
near regression analysis provided y = −0.214x − 0.789, R2 = 0.918. The relative antioxidant activities of phenols 
correlated to their membrane interactivities. 
4. Discussion 
The presence of a certain amount of cholesterol in lipid bilayers decreases the fluidity of membranes [23]. Be-
cause neuronal mimetic membranes were prepared with phospholipids plus cholesterol, they are more rigid than 
the model membranes consisting of DPPC alone. The different membrane-fluidizing potencies of phenols and 
local anesthetics between neuronal mimetic and DPPC membranes are attributed to such a difference of mem-
brane property due to lipid compositions. 
Lidocaine and bupivacaine interacted with neuronal mimetic membranes at 20 - 200 μM, although their ef-
fects were not as great as phenols interacting with the same membranes at 1 - 10 μM. The relative potencies of 
lidocaine and bupivacaine to fluidize the membranes correlate to those of local anesthesia induced by them. A 
 
 
Figure 3. Effects of phenols and local anesthetics on neuronal mimetic mem-
branes. Membranes prepared with phospholipids and cholesterol to mimic 
neuronal membranes were treated with phenols and local anesthetics at the 
indicated concentrations, followed by measuring DPH fluorescence polariza-
tion. The polarization changes (%) relative to control values are shown as 
means ± SEM (n = 6). *P < 0.05 and **P < 0.01 compared with control.         




Figure 4. Effects of membrane-interacting phenols on membrane lipid pe-
roxidation. DPPP-incorporated membranes consisting of unsaturated phos-
pholipids and cholesterol were treated with 10 or 100 μM phenols and 1 μM 
α-tocopherol as a reference antioxidant, and then with 10 μM peroxynitrite, 
followed by the fluorometric analysis. The lipid peroxidation inhibitions (%) 
were determined by comparing the fluorescence intensity with controls. The 
results are shown as means ± SEM (n = 5). *P < 0.05 and **P < 0.01 com-
pared with control.                                                  
 
relatively large volume of high concentration drugs is injected to ensure adequate local anesthesia for surgery, as 
20 - 30 ml of 20 mg/ml lidocaine are typically injected to block large nerves in humans [24]. Nociceptive C-fibers 
of rat sciatic nerves are blocked by continuously superfusing lidocaine of 0.33 mg/ml [25]. Considering clini-
cally/experimentally-relevant and membrane-fluidizing concentrations, the membrane interaction is related to 
local anesthetic effects. 
Even if local anesthetics are concentrated in lipid bilayers so that their intra-membrane concentrations are 
higher than their concentrations in the bulk aqueous phase [26], they could not achieve high micromolar con-
centrations in the CNS. The membrane interactions of lidocaine and bupivacaine are unlikely to contribute to the 
inhibition of GABA-induced currents at membrane-embedded GABAA receptors. 
Thymol, eugenol and propofol penetrate into lipid bilayers to locate in the region between the polar group, the 
glycerol moiety and the acyl chains, with the preference of more lipophilic phenols to the deeper hydrophobic 
region. The structure and membrane activity relation indicated that lipophilicity and 2,6-dialkylphenol structure 
impart greater membrane interactivity to alkylphenols, which is consistent with previous reports [27] [28]. When 
comparing thymol isomers, the position of an isopropyl group is important for membrane interaction as signifi-
cantly different between thymol and MIP, but not that of a methyl group as slightly different between thymol 
and isothymol. Additional substituents at the para-position decreases the membrane interactivity as shown by 
the comparisons of guaiacol, eugenol and phenol, and a 2-propenyl group is preferable to a 1-propenyl group as 
seen in a difference between eugenol and isoeugenol. 
When orally and intravenously administered, alkylphenols show the effects on central and peripheral nerves 
[1] [2]. In specimens from a forensic autopsy case of a man intravenously misinjected with 500 mg propofol, its 
determined concentrations were 26.8 ng/ml in blood and 129.6 ng/g in brain [29]. Higher lipophilic propofol and 
thymol are able to cross the blood-brain barrier and penetrate into neuronal membranes where they are concen-
trated. Alkylphenols concentrated in brains and nerve cells should be low micromolar levels or less, at which 
they could interact with membrane lipids [28] [30]. Lipid bilayer membranes mediate the effects of drugs 
through their induced perturbation of membrane structures, physicochemical properties or dynamics [14]. Mem-
brane fluidity, curvature, elasticity and dipolar arrangement modulate the receptor-mediated interactions be-
tween drugs and membranes [31]. The anesthetic effects of alkylphenols are referred to as the combined results 
of their interactions with receptor or channel proteins and those with membrane lipids to modify the lipid envi-
ronments surrounding such functional proteins [32]. 
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Phenols like eugenol applied to pulp cavities achieve the concentrations in dental pulps and dentins adjacent 
to the pulp space to be 10 - 100 μM, but their concentrations are unlikely to be in excess of 0.1 mM in pulp tis-
sues [33] [34]. Dental phenols show the concentration-dependent effects: pulp-sedative at relatively low concen-
trations but irritant or cytotoxic at relatively high concentrations [35]. Membrane-active phenols would reversi-
bly exert anesthetic and analgesic effects by acting on neuronal membranes at low micromolar concentrations 
which cover their membrane-interacting concentrations. At high micromolar or millimolar concentrations, how-
ever, they are assumed to irreversibly damage neural and pulp tissues by the lysis of lipid membranes as alkyl-
phenols adversely acted on DPPC model membranes. 
Compounds to positively modulate GABAA receptors possess the antioxidant activity, which may lead to the 
neuro-protection [27]. Antioxidant dugs are expected to reduce oxidative stress in the perioperative period and 
ischemia/reperfusion injury [36]. While the antioxidant activity of drugs has been frequently evaluated by the 
inhibition of lipid peroxidation, lipid samples are treated with hydroxyl, ferryl, tert-butyl hydroperoxide and 2,2- 
diphenyl-1-picrylhydrazyl radicals in a homogenous or aqueous phase. These experimental conditions do not 
necessarily reflect the in vivo lipid peroxidation. Peroxynitrite produced from nitric oxide and superoxide anion 
plays a crucial role for the membrane lipid peroxidation in myocardial ischemia/reperfusion [37], and its perox-
idation ability is modulated by the antioxidant mechanism [38]. According to the in vivo pathogenic oxidation, 
the antioxidant effects of phenols were determined by the phospholipid bilayer membranous system using pe-
roxynitrite. Consequently, several phenols have been revealed to show promising effects with the rank order of 
lipid peroxidation inhibition being propofol > thymol > isothymol > guaiacol > phenol > eugenol, consistent 
with that of neuronal mimetic membrane fluidization. The basic structure of phenol and substituents at the ortho- 
position appear to potentiate both membrane interaction and lipid peroxidation inhibition, but substituents at the 
para-position reduce [21] [27]. 
The peroxidation rate of membrane lipids depends on the propagation of oxidant and antioxidant molecules in 
lipid bilayers which is determined by membrane physicochemical properties such as fluidity [39]. The tested 
phenols are considered to interact more efficiently with radicals in more fluid lipid bilayers [40]. Their mem-
brane-fluidizing effects are preferable to make the interaction between antioxidant molecules and radicals more 
efficient [41]. 
5. Conclusion 
Phenols interact with the membranes consisting of unsaturated phospholipids and cholesterol to modify their 
fluidity with the potency correlating to anesthetic effects. The structure and membrane activity relation indicates 
that branched-chain alkyl groups in the ortho-position relative to a hydroxyl group increase the membrane inte-
ractivity, but additional substituents at the para-position decrease. Thymol and propofol meeting the structural 
requirements show the greatest membrane interaction at clinically-relevant concentrations. The structure- 
specific membrane interaction likely underlies the pharmacology of anesthetic phenols. Since the interaction 
with unsaturated phospholipid membranes could be associated with the inhibition of membrane lipid peroxida-
tion, membrane-interacting antioxidant alkylphenols may be effective in protecting against the peroxynitrite- 
relating ischemia/reperfusion injury. 
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